Suppr超能文献

沙特一家三级医疗中心老年内科患者的静脉血栓栓塞预防用药模式:成功还是失败?

Venous thromboembolism prophylaxis-prescribing patterns among elderly medical patients in a Saudi tertiary care center: success or failure?

作者信息

Alabdulkarim Dalal A, Almohammed Omar A, Al Ammari Maha A, Almaklafi Nada S, Alkathiri Munirah A, Aljohani Manal A

机构信息

Pharmaceutical Care Service, Ministry of the National Guard-Health Affairs, Riyadh, Saudi Arabia.

King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.

出版信息

J Geriatr Cardiol. 2020 Dec 28;17(12):775-781. doi: 10.11909/j.issn.1671-5411.2020.12.004.

Abstract

BACKGROUND

Hospitalized elderly patients are at high risk of venous thromboembolism (VTE), and the appropriate use of thromboprophylaxis can significantly reduce the incidence of VTE in high-risk patients. We investigated the pattern of VTE prophylaxis administration among elderly medical patients and assessed its appropriateness based on the American College of Chest Physicians (ACCP) recommendations.

METHODS

A cross-sectional single-center study was conducted between October 2019 and March 2020, including hospitalized (> 48 h), elderly (≥ 60 years), medical patients, and excluding patients receiving anticoagulant for other reason, having contraindication to thromboprophylaxis, or had VTE diagnosed within 48 h. The Padua prediction score was used to determine the patients' risk for VTE, and thromboprophylaxis use was assessed against the ACCP recommendations.

RESULTS

The study included 396 patients with an average age of 75.0 ± 9.01 years, and most patients (71.7%) were classified as high risk for VTE development (Padua score ≥ 4 points). Thromboprophylaxis use was inappropriate in 27.3% of patients, of whom 85.2% were ineligible but still received thromboprophylaxis. Patients who were classified as low risk of VTE were more likely to receive inappropriate thromboprophylaxis (AOR = 76.5, 95% CI: 16.1-363.2), whereas patients with acute infection or rheumatologic disorder were less likely to receive inappropriate thromboprophylaxis (AOR = 0.46, 95% CI: 0.22-0.96).

CONCLUSIONS

Although the use of thromboprophylaxis among high-risk elderly patients was reasonably adequate, a large proportion of low-risk patients were exposed to unnecessary risk through inappropriate overutilization of thromboprophylaxis. Thus, healthcare providers should accurately assess patients' risk before prescribing thromboprophylaxis to ensure patient safety.

摘要

背景

住院老年患者发生静脉血栓栓塞症(VTE)的风险很高,适当使用血栓预防措施可显著降低高危患者VTE的发生率。我们调查了老年内科患者VTE预防措施的使用模式,并根据美国胸科医师学会(ACCP)的建议评估其合理性。

方法

于2019年10月至2020年3月进行了一项横断面单中心研究,纳入住院(>48小时)、老年(≥60岁)内科患者,排除因其他原因接受抗凝治疗、有血栓预防禁忌证或在48小时内被诊断为VTE的患者。使用帕多瓦预测评分来确定患者发生VTE的风险,并根据ACCP的建议评估血栓预防措施的使用情况。

结果

该研究纳入了396例患者,平均年龄为75.0±9.01岁,大多数患者(71.7%)被归类为发生VTE的高危患者(帕多瓦评分≥4分)。27.3%的患者血栓预防措施使用不当,其中85.2%不符合条件但仍接受了血栓预防措施。被归类为VTE低风险的患者更有可能接受不适当的血栓预防措施(调整后比值比[AOR]=76.5,95%置信区间[CI]:16.1-363.2),而患有急性感染或风湿性疾病的患者接受不适当血栓预防措施的可能性较小(AOR=0.46,95%CI:0.22-0.96)。

结论

虽然高危老年患者血栓预防措施的使用基本合理,但很大一部分低风险患者因不适当的过度使用血栓预防措施而面临不必要的风险。因此,医疗保健提供者在开出血栓预防药物之前应准确评估患者的风险,以确保患者安全。

相似文献

2
Safety and effectiveness of thromboprophylaxis use in hospitalized elderly medical patients at a Saudi tertiary care center.
Saudi Pharm J. 2021 May;29(5):456-461. doi: 10.1016/j.jsps.2021.04.008. Epub 2021 Apr 28.
3
Thromboprophylaxis rates in US medical centers: success or failure?
J Thromb Haemost. 2007 Aug;5(8):1610-6. doi: 10.1111/j.1538-7836.2007.02650.x.
6
An assessment of surgical thromboprophylaxis in a tertiary care center.
Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E39-45. doi: 10.1177/1076029610382652. Epub 2010 Sep 9.
8
Incidence of thromboembolism and thromboprophylaxis in medical patients admitted to specialized hospital in Ethiopia using Padua prediction score.
SAGE Open Med. 2022 Feb 21;10:20503121221079488. doi: 10.1177/20503121221079488. eCollection 2022.

引用本文的文献

本文引用的文献

1
Deep vein thrombosis: pathogenesis, diagnosis, and medical management.
Cardiovasc Diagn Ther. 2017 Dec;7(Suppl 3):S276-S284. doi: 10.21037/cdt.2017.09.01.
2
Predictors and Outcomes of Recurrent Venous Thromboembolism in Elderly Patients.
Am J Med. 2018 Jun;131(6):703.e7-703.e16. doi: 10.1016/j.amjmed.2017.12.015. Epub 2018 Jan 4.
4
Venous thromboembolism risks and prophylaxis in King Fahad Hospital, Madinah, Saudi Arabia.
J Epidemiol Glob Health. 2017 Dec;7(4):295-298. doi: 10.1016/j.jegh.2017.09.003. Epub 2017 Sep 22.
5
Venous thromboembolism in the elderly: A narrative review.
Thromb Res. 2017 Jul;155:140-147. doi: 10.1016/j.thromres.2017.05.015. Epub 2017 May 17.
6
7
Lifetime Risk of Venous Thromboembolism in Two Cohort Studies.
Am J Med. 2016 Mar;129(3):339.e19-26. doi: 10.1016/j.amjmed.2015.10.014. Epub 2015 Nov 18.
8
10
Cost-effectiveness of prevention and treatment of VTE.
Clin Appl Thromb Hemost. 2013 Mar-Apr;19(2):220-3. doi: 10.1177/1076029612474840v.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验